CN101343315B - 截短的人乳头瘤病毒6型l1蛋白 - Google Patents
截短的人乳头瘤病毒6型l1蛋白 Download PDFInfo
- Publication number
- CN101343315B CN101343315B CN2008101113904A CN200810111390A CN101343315B CN 101343315 B CN101343315 B CN 101343315B CN 2008101113904 A CN2008101113904 A CN 2008101113904A CN 200810111390 A CN200810111390 A CN 200810111390A CN 101343315 B CN101343315 B CN 101343315B
- Authority
- CN
- China
- Prior art keywords
- viruslike particle
- vaccine
- hpv
- albumen
- hpv6
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5258—Virus-like particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C07K14/01—DNA viruses
- C07K14/025—Papovaviridae, e.g. papillomavirus, polyomavirus, SV40, BK virus, JC virus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2796/00—Viruses not covered by groups C12N2710/00 - C12N2795/00
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/01—DNA viruses
- G01N2333/025—Papovaviridae, e.g. papillomavirus, polyomavirus, SV40, BK virus, JC virus
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Biomedical Technology (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Dermatology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
Na2HPO4 | 6g |
KH2PO4 | 3g |
NaCl | 0.5g |
NH4Cl | 1g |
酪蛋白水解物 | 20g |
MgCl2 | 0.095g |
Claims (19)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2008101113904A CN101343315B (zh) | 2007-05-29 | 2008-05-29 | 截短的人乳头瘤病毒6型l1蛋白 |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200710105764.7 | 2007-05-29 | ||
CN200710105764 | 2007-05-29 | ||
CN2008101113904A CN101343315B (zh) | 2007-05-29 | 2008-05-29 | 截短的人乳头瘤病毒6型l1蛋白 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101343315A CN101343315A (zh) | 2009-01-14 |
CN101343315B true CN101343315B (zh) | 2012-06-13 |
Family
ID=40074567
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2008101113904A Active CN101343315B (zh) | 2007-05-29 | 2008-05-29 | 截短的人乳头瘤病毒6型l1蛋白 |
Country Status (7)
Country | Link |
---|---|
US (2) | US8748127B2 (zh) |
EP (1) | EP2154149B1 (zh) |
CN (1) | CN101343315B (zh) |
BR (1) | BRPI0810951B8 (zh) |
DK (1) | DK2154149T3 (zh) |
HK (1) | HK1124343A1 (zh) |
WO (1) | WO2008145021A1 (zh) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR112013000031A2 (pt) * | 2010-07-02 | 2016-05-10 | Xiamen Innovax Biotech Co Ltd | proteína l1 hpv52 truncada ou variante da mesma, ácido nucleíco isolado, vetor, célula hospedeira, partícula do tipo viral hpv52, composição, composição farmacêutica ou vacina, método para obter uma proteína l1 hpv52 truncada, método para preparar a partícula do tipo viral hpv52, método para preparar uma vacina, método para prevenir a infecção hpv ou uma doença causada pela infecção de hpv e uso da proteína l1 hpv52 truncada ou variante da mesma |
CN102229660B (zh) | 2011-05-25 | 2015-04-22 | 厦门大学 | 截短的人乳头瘤病毒33型l1蛋白 |
CN105002190B (zh) * | 2013-12-03 | 2022-11-08 | 北京康乐卫士生物技术股份有限公司 | 11型重组人乳头瘤病毒病毒样颗粒及其制备方法 |
EP3364982A4 (en) * | 2015-10-22 | 2019-04-17 | ModernaTX, Inc. | VACCINES AGAINST SEXUALLY TRANSMITTED DISEASES |
CN106831960B (zh) * | 2015-12-04 | 2019-11-05 | 厦门大学 | 一种人乳头瘤病毒6型l1蛋白的突变体 |
US10513541B2 (en) | 2015-12-04 | 2019-12-24 | Xiamen University | Mutant of L1 protein of human papillomavirus type 11 |
JP7265563B2 (ja) | 2018-06-04 | 2023-04-26 | シアメン ユニバーシティ | ヒトパピローマウイルス18型のl1タンパク質の変異体 |
CN114539364B (zh) * | 2020-11-26 | 2023-10-20 | 中国医学科学院基础医学研究所 | 一种c端改造的人乳头瘤病毒6型l1蛋白及其用途 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000054730A2 (en) * | 1999-03-18 | 2000-09-21 | The President & Fellows Of Harvard College | Compositions preparations and uses of human papillomavirus l1 protein |
WO2003078455A2 (en) * | 2002-03-18 | 2003-09-25 | Glaxosmithkline Biologicals Sa | Virus like particle from papillomavirus and their use in vaccine |
CN1478790A (zh) * | 2002-08-30 | 2004-03-03 | 马润林 | 乳头瘤病毒衣壳蛋白的原核制备和应用 |
CN101153280A (zh) * | 2006-09-29 | 2008-04-02 | 厦门大学 | 从原核生物中纯化人乳头瘤病毒晚期蛋白l1的方法 |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3110561A1 (de) * | 1981-03-18 | 1982-11-04 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen | Chemorekrutine der leukozyten und des entszuendungsgewebes: eine neue klasse natuerlicher leukopoetine zurselektiven chemorekrutierung von leukozyten aus dem knochenmark in den blutstrom (leukozytose- und linskverschiebungsreaktion) |
FR2672895B1 (fr) * | 1991-02-15 | 1995-05-12 | Transgene Sa | Procede de purification d'une proteine fortement glycosylee. |
PT1618888E (pt) * | 1993-03-09 | 2011-04-08 | Univ Rochester | Produção de proteína da cápside de vírus de papiloma humano e partículas semelhantes a vírus |
AUPM566794A0 (en) * | 1994-05-17 | 1994-06-09 | University Of Queensland, The | Process and product |
IL113817A (en) * | 1994-06-30 | 2001-03-19 | Merck & Co Inc | Polynucleotide for vaccination against the umbilical cord virus |
ATE325875T1 (de) * | 1994-10-07 | 2006-06-15 | Univ Loyola Chicago | Papillomavirusähnliche partikel, fusionsproteine sowie verfahren zu deren herstellung |
US7351533B2 (en) * | 1997-09-05 | 2008-04-01 | Medimmune, Inc. | In vitro method for disassmbly/reassembly of papillomavirus virus-like particles (VLPs). Homogeneous VLP and cavsomere compositions produced by said methods: use thereof as vehicle for improved purification, and delivery of active agents |
US6228368B1 (en) * | 1997-10-06 | 2001-05-08 | Loyola University Of Chicago | Papilloma virus capsomere formulations and method of use |
US7182947B2 (en) * | 1998-02-20 | 2007-02-27 | Medigene Ag | Papillomavirus truncated L1 protein and fusion protein constructs |
US20020193565A1 (en) * | 1998-03-27 | 2002-12-19 | Stanley Margaret Anne | Antigen preparation and use |
EA200100236A1 (ru) * | 1998-08-14 | 2001-08-27 | Мерк Энд Ко., Инк. | Способ очистки вирусных частиц, подобных вирусу папилломы человека |
GB0206360D0 (en) * | 2002-03-18 | 2002-05-01 | Glaxosmithkline Biolog Sa | Viral antigens |
MY139500A (en) * | 2003-11-12 | 2009-10-30 | Merck Sharp & Dohme | Optimized expression of hpv 58 l1 in yeast |
GB0624227D0 (en) * | 2006-12-05 | 2007-01-10 | Common Services Agency | Protein purification |
US7709010B2 (en) * | 2007-03-09 | 2010-05-04 | Merck Sharp & Dohme Corp. | Papillomavirus vaccine compositions |
BRPI0815818A2 (pt) * | 2007-04-29 | 2016-08-02 | Beijing Wantai Biological Pharmacy Entpr Co Ltd | proteína l1 truncada do papiloma vírus humano tipo 18 |
WO2008134934A1 (en) * | 2007-04-29 | 2008-11-13 | Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. | A truncated l1 protein of human papillomavirus 16 |
EP2907821B1 (en) * | 2007-05-29 | 2016-12-28 | Xiamen University | Method for producing a N-terminaly truncated L1 protein of human papillomavirus (HPV) |
-
2008
- 2008-05-29 BR BRPI0810951A patent/BRPI0810951B8/pt active IP Right Grant
- 2008-05-29 US US12/601,972 patent/US8748127B2/en active Active
- 2008-05-29 DK DK08757381.2T patent/DK2154149T3/da active
- 2008-05-29 WO PCT/CN2008/001050 patent/WO2008145021A1/zh active Application Filing
- 2008-05-29 EP EP08757381.2A patent/EP2154149B1/en active Active
- 2008-05-29 CN CN2008101113904A patent/CN101343315B/zh active Active
-
2009
- 2009-03-03 HK HK09102006.9A patent/HK1124343A1/xx unknown
-
2014
- 2014-04-08 US US14/248,063 patent/US9745351B2/en active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000054730A2 (en) * | 1999-03-18 | 2000-09-21 | The President & Fellows Of Harvard College | Compositions preparations and uses of human papillomavirus l1 protein |
WO2003078455A2 (en) * | 2002-03-18 | 2003-09-25 | Glaxosmithkline Biologicals Sa | Virus like particle from papillomavirus and their use in vaccine |
CN1478790A (zh) * | 2002-08-30 | 2004-03-03 | 马润林 | 乳头瘤病毒衣壳蛋白的原核制备和应用 |
CN101153280A (zh) * | 2006-09-29 | 2008-04-02 | 厦门大学 | 从原核生物中纯化人乳头瘤病毒晚期蛋白l1的方法 |
Non-Patent Citations (1)
Title |
---|
W.Caparros-Wanderley et al.Intratype sequence variation among clinical isolates of the human papillomavirus type 6 L1 ORF:clustering of mutations and identification of a frequent amino acid sequence variant.《Journal of General Virology》.1999,第80卷1025-1033. * |
Also Published As
Publication number | Publication date |
---|---|
US9745351B2 (en) | 2017-08-29 |
DK2154149T3 (da) | 2019-10-14 |
EP2154149A1 (en) | 2010-02-17 |
US20100255021A1 (en) | 2010-10-07 |
EP2154149B1 (en) | 2019-07-10 |
BRPI0810951A2 (pt) | 2015-07-21 |
HK1124343A1 (en) | 2009-07-10 |
WO2008145021A1 (en) | 2008-12-04 |
US20140288283A1 (en) | 2014-09-25 |
US8748127B2 (en) | 2014-06-10 |
CN101343315A (zh) | 2009-01-14 |
BRPI0810951B8 (pt) | 2021-05-25 |
EP2154149A4 (en) | 2011-04-06 |
BRPI0810951B1 (pt) | 2020-10-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101293918B (zh) | 截短的人乳头瘤病毒16型l1蛋白 | |
CN101343314B (zh) | 截短的人乳头瘤病毒11型l1蛋白 | |
CN101343315B (zh) | 截短的人乳头瘤病毒6型l1蛋白 | |
CN102229660B (zh) | 截短的人乳头瘤病毒33型l1蛋白 | |
CN101570571B (zh) | 截短的人乳头瘤病毒18型l1蛋白 | |
CN101153280B (zh) | 从原核生物中纯化人乳头瘤病毒晚期蛋白l1的方法 | |
CN102336822B (zh) | 截短的人乳头瘤病毒58型l1蛋白 | |
CN103936840A (zh) | 重组的人乳头瘤病毒33型l1蛋白及其用途 | |
CN104211782B (zh) | 截短的人乳头瘤病毒45型l1蛋白 | |
CN103992395A (zh) | 重组hpv-58型l1的vlp疫苗及其制备方法 | |
CN103819543A (zh) | 重组的人乳头瘤病毒6型l1蛋白及其用途 | |
CN104045696A (zh) | 重组的人乳头瘤病毒16型l1蛋白及其用途 | |
CN104045695A (zh) | 重组的人乳头瘤病毒18型l1蛋白及其用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1124343 Country of ref document: HK |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: GR Ref document number: 1124343 Country of ref document: HK |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20190724 Address after: Siming District of Xiamen city in Fujian Province, 361005 South Siming Road No. 422 Co-patentee after: Xiamen Innovax Biotech Co., Ltd. Patentee after: Xiamen University Address before: Siming District of Xiamen city in Fujian Province, 361005 South Siming Road No. 422 Co-patentee before: Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. Patentee before: Xiamen University |